Fig_9.tif (6.97 MB)

Rescue effect of kinetin on IKBKAP expression and concomitantly on in FD-hESC derived PNS neurons.

Download (0 kB)
figure
posted on 05.10.2015 by Sharon Lefler, Malkiel A. Cohen, Gal Kantor, David Cheishvili, Aviel Even, Anastasya Birger, Tikva Turetsky, Yaniv Gil, Sharona Even-Ram, Einat Aizenman, Nibal Bashir, Channa Maayan, Aharon Razin, Benjamim E. Reubinoff, Miguel Weil

(A) RT-PCR results of one day kinetin treatment on FD-hESC derived PNS neurons showing the drug correcting effect on FD alternative splicing. (B) qRT-PCR analysis of the relative quantification levels represented as mean ± s.d. of IKBKAP and co-regulated functional candidates in FD neurons following one day kinetin treatment. * P<0.05 **P<0.01. (C-K) Effect of 4 weeks kinetin treatment on the expression of IKAP in FD-hESC derived PNS neurons (C-D, untreated and E-F, 4 weeks kinetin treated by immunofluorescence confocal analysis. (G) Quantification of IKAP mean levels calculated from mean RGB after 4 weeks kinetin treatment on these cells (C-K). * P<0.05. (H-K) Effect of 4 weeks kinetin treatment (J and K) on the expression of Rab3a (H and J) and GRIA1 (I and K) in FD-hESC derived PNS neurons by immunofluorescence confocal analysis. Mouse anti-hIKAP antibody (Abnova Corporation) was used in these experiments.

History

Licence

Exports